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A B S T R A C T
Childhood trauma has been proposed to increase vulnerability to develop psychopathology in part through an
altered cortisol stress response. Research in rats has suggested that this eﬀect is mediated by methylation in the
glucocorticoid receptor 17 region (GR-17 or GR-1F in humans), with higher methylation after poor maternal care
leading to an increased cortisol stress response in adulthood. In humans, the associations between childhood
trauma and GR-1F methylation or the cortisol stress response are equivocal. Remarkably, evidence for the re-
lation between GR-1F methylation and the cortisol stress response has been conﬂicting as well. To further explore
this, we investigated the associations of peripheral GR-1F methylation (52 CpGs) with the cortisol stress response
(Trier Social Stress Test) and with childhood trauma in three independent studies (total N=241) including
healthy controls, patients with schizophrenia and bipolar disorder and unaﬀected siblings of patients with one of
these disorders. We did not ﬁnd any signiﬁcant association between GR-1F methylation and the cortisol stress
response (areas under the curve) or childhood trauma, nor did we observe any group diﬀerences between pa-
tients, siblings and healthy controls. Our ﬁndings do not support GR-1F methylation as a proxy for the cortisol
stress response, nor its link with childhood trauma or psychopathology. These results suggest that multifactorial
models for stress-related psychopathology are needed. Alternatively, future longitudinal studies may reveal GR-
1F methylation to be a useful parameter at an individual level.
1. Introduction
Stress is arguably the most common environmental factor leading to
psychopathology (Smoller, 2016), and its eﬀects are especially detri-
mental when occurring during childhood (Carr et al., 2013; Nanni et al.,
2012). This persisting impact of stress during development is thought to
be partially mediated by epigenetic mechanisms. A seminal study in
2004 proposed the 1F region of the glucocorticoid receptor (GR) to be of
crucial importance in this context (Weaver et al., 2004). Pups of low
licking-grooming dams showed higher methylation in the rat ortholog
of the 1F region, which was linked to impaired feedback by corticos-
terone on the hypothalamus-pituitary-adrenal (HPA) axis in adulthood,
irrespective of the genetic background (Weaver et al., 2004).
This appealing observation stimulated a considerable amount of
translational research in humans, where GR-1F methylation was eval-
uated in relation to (childhood) trauma, HPA axis functionality and
stress-related psychopathology (Daskalakis and Yehuda, 2014). Con-
sidering the ambiguous relationship between childhood trauma and
HPA axis activity (e.g. (Heim et al., 2000) and (Lovallo et al., 2012)), it
is not surprising that childhood trauma can be positively (Van der
Knaap et al., 2014), negatively (Tyrka et al., 2016) or not associated
with GR-1F methylation (Schür et al., 2017). Similarly, the relationship
between GR-1F methylation and stress-related psychopathology is not
straightforward either, with conﬂicting ﬁndings in both major depres-
sive disorder (MDD) (Na et al., 2014; Nantharat et al., 2015) and
posttraumatic stress disorder (PTSD) (Perroud et al., 2014; Yehuda
et al., 2015).
Remarkably, however, the link between GR-1F methylation and
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HPA axis functionality in humans is not clear-cut either. Several studies
conﬁrmed impaired negative feedback on the HPA axis by elevated GR-
1F methylation. Two studies showed a positive relationship between
GR-1F methylation and cortisol levels after dexamethasone and/or CRH
(Tyrka et al., 2016; Yehuda et al., 2015), even though the relation was
not strong (r< 0.2). In line with this, two other studies found that
higher GR-1F methylation was linked to elevated cortisol levels fol-
lowing a social stress test, albeit either in the acute phase (Alexander
et al., 2018) or in the recovery phase of the stress response (van der
Knaap et al., 2015). In contrast, two other studies showed associations
in the opposite direction, using the Trier Social Stress Test (TSST) and
the dexamethasone/CRH test, respectively (Edelman et al., 2012; Tyrka
et al., 2012). This equivocal evidence asks for large additional studies to
evaluate whether GR-1F methylation represents a useful proxy for HPA
axis functionality or not.
In the present study, we used data from three independent cohorts
to further explore the relationship between GR-1F methylation and the
cortisol stress response. We hypothesized that elevated methylation
would be associated with an increased cortisol stress response and ex-
pected positive associations of GR-1F methylation with childhood
maltreatment. Moreover, as the association between GR-1F methylation
and psychotic disorders has not been thoroughly investigated yet, we
explored this relationship in patients with either schizophrenia or bi-
polar disorder, siblings of such patients and controls.
2. Methods
2.1. Participants
The present study combined data from three diﬀerent cohorts, of
which previously diﬀerent aspects have been described (Houtepen
et al., 2015; Van Leeuwen et al., 2018; Vinkers et al., 2013; Zorn et al.,
2017). Brieﬂy, Vinkers et al. (2013) investigated time-dependent eﬀects
of stress on altruistic punishment in healthy controls, taking the cortisol
stress response into account (see Table 1, cohort 1). Houtepen et al.
(2015) evaluated medication eﬀects on the cortisol stress response in
euthymic patients with bipolar disorder, unaﬀected siblings of patients
with bipolar disorder (unrelated to the patients with bipolar disorder)
and healthy controls (see Table 1, cohort 2). Moreover, data from 13
schizophrenia patients were added to this sample (Zorn et al., 2017).
Finally, Van Leeuwen et al. (Van Leeuwen et al., 2018) examined the
cortisol stress response in relation to functional brain activity in un-
aﬀected siblings of schizophrenia patients versus controls (see Table 1,
cohort 3).
In all studies, lifetime DSM-IV diagnoses in healthy individuals were
assessed with the Mini International Neuropsychiatric Interview (MINI)
plus (Sheehan et al., 1998). Diagnosis in patients with bipolar disorder
or schizophrenia was conﬁrmed using the Structured Clinical Interview
for DSM-IV (SCID) (First et al., 2002). The Young Mania Rating Scale
(YMRS, range 0–7 (Tohen et al., 2000; Young et al., 1978)) and the 30-
item Inventory of Depressive Symptomatology (IDS-C30, range 0–24
(Rush et al., 1996)) were used to conﬁrm euthymic mood in patients
with bipolar disorder (Houtepen et al., 2015). All interviews were
carried out by well-trained and independent raters.
Use of medication (lithium, antidepressants, anticonvulsants, anti-
psychotics and beta blockers) and drugs of abuse (including nicotine)
was determined with a self-report questionnaire. In addition, multi-
drug screening devices were employed to assess current use of psy-
choactive substances (benzodiazepines, cannabinoids, opiates, cocaine,
amphetamines, and either MDMA and barbiturates (InstantView, co-
horts 1 and 2) or methadone (Multi-line, cohort 3)). For female parti-
cipants, information on contraceptive medication use and menstrual
cycle was collected, as these variables are associated with altered HPA
axis reactivity (Kirschbaum et al., 1999). The studies were approved by
the ethical review board of the University Medical Center Utrecht
(UMCU) and performed in accordance with the Declaration of Helsinki
and the ICH guidelines for Good Clinical Practice. Prior to inclusion, all
participants provided written informed consent.
2.2. Procedures
2.2.1. Trier social stress test
All participants were new to stress research and were subjected to
the stress condition of the TSST (Kirschbaum et al., 1993), consisting of
a public speaking test and a subsequent mental arithmetic test. All
participants were ﬂuent in Dutch and refrained from heavy exercise,
heavy meals, or drinks other than water for at least 2 h prior to the TSST
(caﬀeine use was not allowed within 4 h of the TSST). Patients with
bipolar disorder or schizophrenia, siblings of patients with bipolar
disorder and 99 healthy controls were subjected to the group version of
the TSST (see for a more detailed description (von Dawans et al.,
2011)). Participants enrolled in the same TSST (up to four in total) were
Table 1
Characteristics Table.
Cohort 1 2 3 All
Group status Control BD pt SCZ pt BD sib Control SCZ sib Control
N 51 43 13 24 48 30 32 241
Sex
% male
47 49 54 29 50 100 100 60
Age
mean (sd)
22.6 (2.5) 43.9 (12.9) 40.1 (15.0) 55.8 (7.1) 43.4 (15.9) 32.6 (8.9) 32.9 (8.0) 37.4 (14.7)
Childhood trauma
mean (sd)
30.5 (6.4) 37.1 (10.7) 30.5 (6.4) 35.0 (11.3) 33.2 (10.0) 34.2 (7.8) 35.3 (12.2) 33.8 (9.7)
Emotional abuse
mean (sd)
6.8 (2.5) 8.6 (4.0) 6.6 (3.2) 7.8 (3.1) 7.2 (3.8) 6.9 (1.9) 7.1 (3.3) 7.3 (3.3)
Physical abuse
mean (sd)
5.2 (0.5) 5.3 (0.7) 5.2 (0.6) 5.5 (1.6) 5.3 (0.8) 5.4 (1.1) 6.0 (3.7) 5.4 (1.6)
Sexual abuse
mean (sd)
4.1 (0.3) 5.1 (3.3) 4.2 (0.8) 4.9 (3.1) 4.5 (1.3) 5.4 (2.2) 5.3 (0.9) 4.7 (2.0)
Emotional neglect
mean (sd)
9.0 (3.8) 11.8 (5.0) 9.4 (4.5) 10.6 (3.1) 10.2 (4.8) 10.3 (3.7) 9.8 (4.4) 10.2 (4.3)
Physical neglect
mean (sd)
5.8 (1.5) 6.7 (1.9) 6.2 (1.8) 6.7 (2.8) 6.4 (2.6) 6.1 (1.8) 7.1 (2.4) 6.4 (2.2)
N no drugs of abuse or medication 51 0 0 19 36 30 32 168
N TSST 49 42 13 24 46 13 17 204
Pooled data from three cohorts were used in the present study (cohort 1 (Vinkers et al., 2013), cohort 2 (Houtepen et al., 2015; Zorn et al., 2017), cohort 3 (Van
Leeuwen et al., 2018). BD=bipolar disorder; pt= patients; SCZ= schizophrenia; sib= siblings; TSST=Trier Social Stress Test.
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unfamiliar to each other. The remaining participants performed the
individual TSST (17 siblings of schizophrenia patients and 15 healthy
controls, for more details see (Van Leeuwen et al., 2018)).
2.2.2. Salivary cortisol samples
Cortisol levels were measured in saliva, which was collected in
salivettes (Sarstedt, Nümbrecht, Germany). Sampling was carried out at
7–8 time points around the start of the TSST, slightly diﬀering between
the original studies (−10, 8, 16, 35, 50, 65, 90 and 125min (Vinkers
et al., 2013); −10, 8, 20, 40, 50, 65, 80 and 85min (Houtepen et al.,
2015);−10, 5, 20, 30, 65, 90 and 120min (Van Leeuwen et al., 2018).
All samples were stored at −80 °C immediately after the TSST and
analyzed as previously described (Vinkers et al., 2013). Brieﬂy, an in
house competitive radio-immunoassay was used to measure cortisol
without extraction. In case of a missing saliva sample, the average of
two surrounding time points was used (Houtepen et al., 2015). All
participants were tested between 12:00 h and 20:30 h to reduce varia-
tion in baseline cortisol levels due to the diurnal rhythm. In total, data
for methylation and the cortisol stress response were available for 204
individuals; 32 individuals of cohort 3 and 2 individuals of cohort 1
were only exposed to a control condition of the TSST, and three in-
dividuals in cohort 2 were excluded as more than one salivette did not
have enough saliva for analysis.
The trapezoidal rule was employed to calculate areas under the
curve of the cortisol stress response. We examined both the AUC with
respect to increase (AUCi) and ground (AUCg), as these measures hold
diﬀerent information (Pruessner et al., 2003). Cohort was added as a
covariate in our statistical models, as AUCs were based on three sets of
slightly diﬀerent time points (cohort 1: mean AUCi= 199, mean
AUCg=1383; cohort 2: mean AUCi= 174, mean AUCg=905; cohort
3: mean AUCi= 30, mean AUCg=947).
2.2.3. GR-1F methylation
Methylation levels were determined at all 47 CpGs in the GR-1F
region, as well as at 5 adjacent CpGs relevant for GR-1F exon tran-
scription (see (Schür et al., 2017)).
Saliva (cohorts 1) and whole blood EDTA (cohorts 2 and 3) samples
were collected at the day of testing and standard procedures were used
to extract DNA (salting for blood and Qiagen extraction kits for saliva).
DNA integrity and concentration were determined using BioAnalyser
(Agilent Technologies, Santa Clara, CA) and riboGreen (Thermo Fisher
Scientiﬁc, Waltham, MA), respectively. Quantiﬁcation of GR-1F me-
thylation was carried out in two batches by EpigenDx (EpigenDx Inc,
MA, USA (Brakensiek et al., 2007; England and Pettersson, 2005; Liu
et al., 2007)) and procedures of quantiﬁcation are more extensively
described elsewhere (Schür et al., 2017). In short, the percentage of
methylation per CpG was determined by considering the CpG site as an
artiﬁcial C/T SNP using QCpG software (Qiagen, Valencia, CA), where
% C equals % methylation as calculated by the equation below:
C% = RLU (C peak)/RLU (C peak+T peak)
All 241 samples yielded suﬃcient pyrosequencing signals and good
quality data (for assays, sensitivity, coeﬃcients of variance, numbers of
CpG sites, and chromosomal regions targeted by the primers, see Table
S1 in the Supplemental Material). In accordance with our previous
study (Schür et al., 2017), we examined mean methylation across all
CpGs, the number of methylated loci (the number of CpGs with> 0%
methylation) and mean methylation at 17 CpGs where methylation
change was signiﬁcantly associated with GR-1F expression change
(termed functional methylation (Schür et al., 2017)). In our measure of
functional methylation, CpG 1 was not included for 179 subjects (co-
horts 1 and 2) as these data were not available. See for mean methy-
lation per CpG Supplemental Table S2.
2.2.4. Childhood trauma
The Childhood Trauma Questionnaire (CTQ) was used in all parti-
cipants to retrospectively determine childhood adversity (Bernstein
et al., 2003). The CTQ comprises the following ﬁve subscales: sexual,
physical and emotional abuse, as well as physical and emotional ne-
glect.
2.3. Statistical analyses
Linear regression models were used to investigate the association
between GR-1F methylation (mean methylation, number of methylated
sites and functional methylation) and the cortisol stress response (AUCi
and AUCg). To adjust for between-cohort diﬀerences in cortisol as-
sessment protocol, tissue type, GR-1F methylation batch (cohort 3 was
measured separately from cohort 1 and 2) and TSST version (individual
or group), cohort was included as factorial covariate. In addition, age,
sex, childhood trauma and group status (two patient groups, two sibling
groups and controls, discussed below) were included as covariates,
yielding the following model: AUC ∼ methylation+ age+ sex+ child-
hood trauma+ cohort+ group status
This model was also used to investigate the association between
childhood trauma and the cortisol stress response (without methylation
as a covariate).
In secondary analyses, linear regression models were used to focus
on the relation between GR-1F methylation and childhood trauma (total
CTQ score and scores on the ﬁve subscales), adjusting for the same
covariates: methylation ∼ age+ sex+ childhood trauma+ co-
hort+ group status
Residual plots of the main models were normally distributed, var-
iance was homogeneous and there was no indication of outliers (all
values of Cook’s Distance<1).
In separate analyses, GR-1F methylation diﬀerences were evaluated
between the following ﬁve groups: healthy controls (n= 131), patients
with bipolar disorder (n=43), schizophrenia patients (n=13), sib-
lings of patients with bipolar disorder (n=24) and siblings of schizo-
phrenia patients (n=30). First, to remove unwanted covariation, re-
siduals of the following model were obtained: methylation ∼
age+ sex+ childhood trauma+ cohort Subsequently, ANOVAs were
used with these residuals as the dependent variable and group status as
the independent variable. As Bartlett’s tests revealed heteroscedasticity
among the groups for mean GR-1F methylation, Welch’s ANOVA for
unequal variances was used for analysis. For the number of methylated
sites non-parametric analyses were done using Kruskal-Wallis tests.
We included results of the analyses per CpG for the cortisol stress
response and childhood trauma in the Supplemental Material as a re-
source for future studies. P-value signiﬁcance in these analyses was set
at< 0.00096 (0.05/52 CpGs), as opposed to< 0.05 in our main ana-
lyses.
2.4. Sensitivity analyses
To rule out possible confounding eﬀects of drugs (including nico-
tine) or medication on the associations between our three GR-1F me-
thylation measures and the cortisol stress response, childhood trauma
or group status, 93 subjects (among which all patients with schizo-
phrenia or bipolar disorder) were excluded in sensitivity analyses.
Moreover, separate sensitivity analyses focusing on the association
between GR-1F methylation and the cortisol stress response were car-
ried out in women (n=96), adjusting for oral contraceptive use, stage
of the menstrual cycle and menstrual status. Finally, for the subset of
participants from whom blood was available (n= 117), white blood
cell types were inferred using DNA methylation signatures (Houseman
et al., 2012), resulting in fractions of natural killer cells, granulocytes,
CD4+ or CD8+ T-lymphocytes, monocytes and B-lymphocytes. To rule
out confounding by cell type, the associations of these fractions with the
main methylation measures (mean methylation, number of methylated
R.R. Schür et al. Psychoneuroendocrinology 97 (2018) 182–189
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sites and functional methylation) were examined. In addition, these
fractions were included as covariates to examine their eﬀects on the
main results.
2.5. Power analysis
GPower (Erdfelder et al., 1996) was used to calculate the power of
our primary analyses. With the current sample size and signiﬁcance
level of 0.05 we have 88% percent power to detect similar eﬀect sizes as
reported by Yehuda et al. (r= 0.198) (Yehuda et al., 2015). However,
for the smaller eﬀect sizes reported by Tyrka et al. (r= 0.148) (Tyrka
et al., 2016) the current study has 68% power.
3. Results
3.1. General
Sample characteristics, including age, sex, childhood trauma and
numbers of subjects in main and secondary analyses are presented in
Table 1, stratiﬁed by cohort and group status.
Of note, childhood trauma was not associated with the cortisol
stress response (AUCi: p= 0.101, β = −4.6; AUCg: p=0.141, β =
−4.2) 3.2. GR-1F methylation and the cortisol stress response
No signiﬁcant associations were found between our three main GR-
1F methylation measures (mean methylation, number of methylated
sites and functional methylation) and the cortisol stress response (AUCi
and AUCg; all p-values> 0.3, see Table 2 and Fig. 1). Moreover, after
multiple comparisons correction, there were no signiﬁcant associations
between the cortisol stress response and GR-1F methylation at the 52
single CpGs (all p-values> 0.00096, see Supplementary Material, Table
S2).
3.2. GR-1F methylation and childhood trauma
GR-1F methylation was not signiﬁcantly associated with the total
level of childhood trauma (all p-values> 0.4, see Table 2 and Fig. 2),
nor with any of the ﬁve subscales: emotional abuse, physical abuse,
sexual abuse, emotional neglect and physical neglect (all p-values>
0.4, see Supplemental Table S3). In addition, analyses at individual
CpGs did not reveal any associations surviving multiple comparisons
correction (all p-values> 0.00096, see Supplementary Material, Table
S2).
3.3. GR-1F methylation in patients, siblings of patients and controls
There were no diﬀerences in GR-1F methylation between any of the
ﬁve groups, after adjusting for age, sex, childhood trauma and cohort
(all p-values> 0.4, see Table 2 and Fig. 3).
3.4. Sensitivity analyses
Excluding subjects using drugs (including nicotine) or medication
did not yield signiﬁcant associations between GR-1F methylation and
the cortisol stress response, childhood trauma, or group status (all p-
values> 0.1, n=122, n= 148 and n=148, respectively; results not
shown). Furthermore, adding the variables oral contraceptive use (yes:
n= 37; no: n=18), stage of the menstrual cycle (luteal phase: n= 26;
follicular phase: n= 5) or menstrual status (premenopausal: n= 59;
postmenopausal: n= 33) to the analyses investigating the association
between GR-1F methylation and the cortisol stress response in women
did not render these associations signiﬁcant (all p-values> 0.1, results
not shown). Finally, none of the white blood cell type fractions were
associated with any of the main methylation measures (all p-values>
0.1). Moreover, inclusion of the white blood cell type fractions in the
main analyses did not yield signiﬁcant associations of GR-1F methyla-
tion with the cortisol stress response, childhood trauma, or group status
(all p-values> 0.2, n=116, n=117 and n=117, respectively; results
not shown).
4. Discussion
The main goal of the present study was to investigate the relation
between GR-1F methylation and the cortisol stress response, as this link
is presumed to be crucial in how (childhood) trauma may increase the
risk to develop psychopathology later in life. To this end, we in-
vestigated the relation between GR-1F methylation in the complete GR-
1F region (52 CpGs) and the cortisol stress response. We did not ﬁnd
any signiﬁcant associations between our main methylation measures
(mean methylation, number of methylated sites and functional me-
thylation) or individual CpGs and the cortisol stress response. In sec-
ondary analyses, we evaluated the relation between GR-1F methylation
and childhood trauma, as well as its link to bipolar disorder and schi-
zophrenia. We found no signiﬁcant associations between childhood
trauma and any of our methylation measures. Moreover, there were no
group diﬀerences in our main methylation measures between patients
with schizophrenia or bipolar disorder, siblings of such patients and
healthy controls.
4.1. GR-1F methylation in relation to HPA axis functionality
The focus of previous studies has been primarily on the relation
between (childhood) trauma and GR-1F methylation, with less con-
sideration for its functional implications. Although GR-1F methylation
is assumed to be positively correlated to HPA axis activity through di-
minished GR-mediated negative feedback (Weaver et al., 2004), results
of studies examining this relation have been surprisingly mixed (for a
review see (Palma-Gudiel et al., 2015)). Using the dexamethasone/
corticotropin-releasing hormone (Dex/CRH) test, Tyrka et al. (Tyrka
et al., 2016) showed a low positive correlation between GR-1F methy-
lation and cortisol levels (n= 231, r= 0.148, p < 0.05). A similar
association (r= 0.198) was found in 114 trauma-exposed military men,
half of whom had developed PTSD (Yehuda et al., 2015). By contrast,
Tyrka et al. (Tyrka et al., 2012) showed a negative correlation between
GR-1F methylation and post-Dex cortisol levels in 99 healthy in-
dividuals (r ≅ −0.25, p < 0.05). Such mixed results have also been
reported for social stress tests. Alexander et al. (Alexander et al., 2018)
found higher peak cortisol levels following the TSST in individuals with
elevated methylation at the most methylated CpG. However, these
Table 2
Results of main analyses.
Outcome AUCi (n= 204) AUCg (n= 204) Childhood trauma (n=241) Group status (n=241)
β p β p β p p
Mean methylation −106.01 0.389 50.48 0.687 0.00088 0.536 0.446
Number of methylated loci −2.78 0.477 2.21 0.578 0.02678 0.559 0.957
Functional methylation −51.52 0.658 102.89 0.384 0.00109 0.479 0.750
Associations of GR-1F methylation with the cortisol stress response (areas under the curve with respect to increase (AUCi) and ground (AUCg)) to the Trier Social
Stress Test, and with childhood trauma. In addition, p-values of methylation diﬀerence by group status (patients with either schizophrenia or bipolar disorder,
siblings of such patients or controls) are presented.
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eﬀects only applied to trauma survivors (n= 31, β=0.203, p= 0.02).
Van der Knaap et al. (van der Knaap et al., 2015) used the Groningen
Social Stress Test in 337 adolescents and found a positive association
between GR-1F methylation and cortisol levels in the recovery phase of
the stress response (β=0.38, p < 0.001), but not with peak cortisol
levels. By contrast, Edelman et al. (Edelman et al., 2012) showed a
negative association between GR-1F methylation and total cortisol se-
cretion during the TSST in 92 individuals (R2= 0.213, p= 0.001).
Based on previously found positive associations between GR-1F me-
thylation and cortisol levels following a functional test, the power in the
present study was between 68 and 88%. The null ﬁnding in the present
study indicates that the functional implications of GR-1F methylation
for HPA axis functionality are not very straightforward, possibly due to
confounders (such as genetic background) that have not yet been
identiﬁed.
4.2. GR-1F methylation in relation to (childhood) trauma
The relation between childhood trauma and GR-1F methylation has
not been very consistent either. After Weaver et al. (Weaver et al.,
2004) demonstrated that early life adversity resulted in elevated GR-1F
methylation in the hippocampus of rats, McGowan et al. (McGowan
et al., 2009) translated this ﬁnding to humans in post-mortem research
of suicide victims and controls. Most subsequent studies in peripheral
Fig. 1. Scatter plots of the cortisol stress response in relation to GR-1F methylation. The associations of the area under the curve with respect to increase (AUCi, upper
pannel) and ground (AUCg, lower panel) with mean methylation (A and D), number of methylated sites (B and E) and functional methylation (C and F) are presented.
The X-axis displays methylation levels adjusted for age, sex, childhood trauma and cohort.
Fig. 2. Scatter plots of GR-1F methylation in relation to childhood trauma. The association of childhood trauma with A. mean methylation, B. number of methylated
sites and C. functional methylation are presented. The Y-axis displays methylation levels adjusted for age, sex and cohort.
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tissues also demonstrated increased GR-1F methylation following in
utero or postnatal adverse events (Daskalakis and Yehuda, 2014). In
addition, our recent longitudinal study showed a positive association
between trauma exposure during military deployment and GR-1F me-
thylation change around deployment (Schür et al., 2017). However, a
large study published in 2016 even reported a negative association
between early life adversity and GR-1F methylation (Tyrka et al., 2016).
Moreover, there are several studies reporting no signiﬁcant association
(Vukojevic et al., 2014; Yehuda et al., 2015). This includes our recent
study where we found no association between childhood trauma and
either basal or longitudinal changes in GR-1F methylation (Schür et al.,
2017). In summary, the current study does not corroborate a positive
association between the total level or any speciﬁc subtype of childhood
trauma and GR-1F methylation and weakens assertions of its biomarker
properties.
4.3. GR-1F methylation in relation to psychopathology
As the functional implications of GR-1F methylation for HPA axis
functionality are equivocal, the same can be expected for its link with
psychopathology. Indeed, eﬀects in opposite directions have been de-
scribed for MDD (Na et al., 2014; Nantharat et al., 2015), PTSD
(Perroud et al., 2014; Yehuda et al., 2015) and general psycho-
pathology as measured using the Symptom Checklist 90 (Schür et al.,
2017; Yehuda et al., 2015). To our knowledge GR-1F methylation had
not yet been investigated in patients with bipolar disorder or schizo-
phrenia (or siblings of such patients) versus healthy controls. Although
the present study did not show altered GR-1F methylation in relation to
these disorders, our group sizes were rather small (13 schizophrenia
patients and 30 siblings; 43 patients with bipolar disorder and 24 sib-
lings) and we could not adjust for possible confounding eﬀects of
medication as all subjects used medication.
4.4. Strengths and limitations
The main strength of this study is its large sample size with data on
the cortisol stress response and GR-1F methylation in the complete GR-
1F region for 204 individuals. Moreover, it is one of the largest studies
investigating the relationship between childhood trauma and GR-1F
methylation (n=241, three studies had larger sample sizes (Martín-
Blanco et al., 2014; Tyrka et al., 2016; Van der Knaap et al., 2014)).
Importantly, in contrast to the vast majority of previous studies on GR-
1F methylation, we investigated all 52 CpGs in this region. Finally, we
included both healthy controls and patients (as well as unaﬀected sib-
lings) with bipolar disorder or schizophrenia.
A limitation of this study is that only the GR-1F region was
investigated, whereas this constitutes only a minor part of the whole
NR3C1 gene (Sinclair et al., 2012). Therefore, it could be argued that
only limited explained variance to the cortisol stress response was to be
expected. We chose to focus particularly on the GR-1F region, as there is
a large body of evidence showing relevance of this speciﬁc region in
relation to childhood trauma, HPA axis functionality and psycho-
pathology, despite generally very low methylation levels (see for ex-
ample (Daskalakis and Yehuda, 2014)). As in almost all previous studies
(Daskalakis and Yehuda, 2014; Tyrka et al., 2016), GR-1F methylation
was determined in peripheral tissues (blood and saliva), with unknown
relevance to the structures where negative feedback on the HPA axis
actually takes place (e.g. the hippocampus). However, cortisol reaches
many diﬀerent cell types and may alter their epigenomes equally
(Turecki and Meaney, 2014). Moreover, a substantial part of the ne-
gative feedback takes place at the level of the pituitary gland, which is
accessible to systemic corticosteroids. Nevertheless, important methy-
lation diﬀerences across cell types and tissues exist (Davies et al., 2012;
Hannon et al., 2015). Of note, we investigated the inﬂuence of white
blood cell types on our main analyses in a subset of participants and
found no changes in results. Other limitations include possible recall
and social desirability bias inherent to the use of the Childhood Trauma
Questionnaire. Furthermore, the number of schizophrenia patients was
low (n=13) and none of these patients or the patients with bipolar
disorder were medication-naïve, making it impossible to exclude con-
founding eﬀects of medication on the relation between psycho-
pathology and GR-1F methylation.
4.5. Conclusion and future directions
Our ﬁndings do not support a role for peripheral GR-1F methylation
as a proxy for cortisol levels in response to stress, nor a link between
GR-1F methylation and childhood trauma or psychopathology.
Although a wider dispersion of GR-1F methylation may yield more
convincing associations, our results are in line with several recent
studies indicating that the application of GR-1F methylation to predict
the cortisol stress response or vulnerability to psychopathology is
complex. Therefore, our results support a cautious use of single biolo-
gical measures and imply a broader and more integrative approach to
explain variance in the cortisol stress response (Houtepen et al., 2016),
as well as the relation between stress and psychopathology. Possibly,
future longitudinal studies may reveal GR-1F methylation to be a useful
parameter at the level of individuals.
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